While overall rates of cervical cancer are decreasing, new studies have shown that late-stage cervical cancer rates are increasing in the U.S., particularly in women 30-34 years of age and in diverse demographics. The cause is unknown but missed screenings could be a factor, experts say.
“If caught early, cervical cancer is highly treatable. These alarming trends in late-stage rates of cervical cancer point to the importance of screening and of seeking highly specialized care if diagnosed with a gynecologic cancer such as cervical cancer,” said Joshua G. Cohen, M.D., F.A.C.O.G., F.A.C.S., a board-certified gynecologic oncologist and medical director of the gynecologic cancer program at City of Hope Orange County.
City of Hope Orange County is offering new hope for women with cervical and other gynecologic cancers, along with world-renowned expertise in gynecologic cancer prevention, urogynecology and gynecologic specialty services.
City of Hope has developed Orange County’s most advanced and comprehensive program for gynecologic oncology and urogynecologic care. The program offers a broad range of expertise in cancer treatment, complex non-cancerous gynecologic disorders, urogynecology and pelvic floor dysfunction.
Patients have access to the latest in “previvorship” prevention, diagnosis, treatment, innovative phase one to three clinical trials, and survivorship care — all providing the greatest hope for recovery and quality of life.
Cervical Cancer Treatment Includes:
- Tailored surgical approach to minimize postoperative recovery and quicker return to normal activities, with the potential for ovarian preservation
- Advanced radiation therapy delivery that is more focused on cancerous cells with less exposure to surrounding normal tissues
- Fertility-preserving therapy options for young women who want to preserve their fertility after cancer treatment
- Individually customized chemotherapy regimens, including novel drugs and drug combinations in our clinical trials program
At City of Hope Orange County, a multidisciplinary team pursues an integrated approach to treating cervical cancer by combining the latest research findings with specialized patient care. Patients have access to the most advanced specialized care in fertility preservation, management of chronic HPV infection, and survivorship.
Dr. Joshua Cohen works alongside his twin brother, Seth A. Cohen, M.D., F.A.C.S., a urologic surgeon, urogynecologist, and program director of the reconstructive urology and cancer survivorship fellowship at City of Hope. Dr. Seth Cohen works to improve quality of life for patients with pelvic floor conditions He manages the side effects related to gynecologic cancers and cancer treatments such as pelvic organ prolapse and urinary incontinence.
For those diagnosed with cancer, new treatments offer better outcomes and fertility and organ-sparing options. Immunotherapy is showing promise, especially in overcoming cancers caused by HPV infection. Treatment involves drugs that activate the immune system to target cancer cells. These include medications that re-engineer T-cells to attack cancer.
There are new paradigm shifts in the management of cervical cancer that are offering new hope to patients and their families.
888-333-HOPE (4673) | CityofHope.org/OC/gyn